JP2013530942A5 - - Google Patents

Download PDF

Info

Publication number
JP2013530942A5
JP2013530942A5 JP2013510192A JP2013510192A JP2013530942A5 JP 2013530942 A5 JP2013530942 A5 JP 2013530942A5 JP 2013510192 A JP2013510192 A JP 2013510192A JP 2013510192 A JP2013510192 A JP 2013510192A JP 2013530942 A5 JP2013530942 A5 JP 2013530942A5
Authority
JP
Japan
Prior art keywords
formula
compound
alkyl
methyl
analog
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013510192A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013530942A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/035654 external-priority patent/WO2011140527A2/en
Publication of JP2013530942A publication Critical patent/JP2013530942A/ja
Publication of JP2013530942A5 publication Critical patent/JP2013530942A5/ja
Pending legal-status Critical Current

Links

JP2013510192A 2010-05-07 2011-05-06 移行型小胞体ａｔｐアーゼの阻害のための方法および組成物 Pending JP2013530942A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33266710P 2010-05-07 2010-05-07
US61/332,667 2010-05-07
PCT/US2011/035654 WO2011140527A2 (en) 2010-05-07 2011-05-06 Methods and compositions for inhibition of the transitional endoplasmic reticulum atpase

Publications (2)

Publication Number Publication Date
JP2013530942A JP2013530942A (ja) 2013-08-01
JP2013530942A5 true JP2013530942A5 (https=) 2014-06-26

Family

ID=44904519

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013510192A Pending JP2013530942A (ja) 2010-05-07 2011-05-06 移行型小胞体ａｔｐアーゼの阻害のための方法および組成物

Country Status (8)

Country Link
US (1) US8865708B2 (https=)
EP (1) EP2566480A4 (https=)
JP (1) JP2013530942A (https=)
KR (1) KR20130128308A (https=)
CN (1) CN103068393A (https=)
AU (1) AU2011249859B2 (https=)
CA (1) CA2798698A1 (https=)
WO (1) WO2011140527A2 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8865708B2 (en) 2010-05-07 2014-10-21 California Institute Of Technology Methods and compositions for inhibition of the transitional endoplasmic reticulum ATPase
US8906918B1 (en) * 2012-03-23 2014-12-09 University Of South Florida (A Florida Non-Profit Corporation) Compositions, methods of use, and methods of treatment
US9062026B2 (en) 2012-07-20 2015-06-23 Cleave Biosciences, Inc. Fused pyrimidines and substituted quinazolines as inhibitors of p97
CA2896731A1 (en) 2012-12-28 2014-07-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Inhibitors of the usp1/uaf1 deubiquitinase complex and uses thereof
US10479777B2 (en) 2013-07-16 2019-11-19 Basf Se Herbicidal azines
DE102013110714A1 (de) * 2013-09-27 2015-04-02 Eberhard Karls Universität Tübingen Medizinische Fakultät Prophylaxe und Behandlung einer nicht auf einer Proteinfaltungsstörung beruhenden neurodegenerativen Erkrankung
CN105828823B (zh) * 2013-10-18 2019-06-14 美国印第安纳大学研究和技术公司 乙型肝炎病毒组装效应物
TW201605832A (zh) 2013-12-10 2016-02-16 克立弗生物科學公司 作為ｐ９７錯合物之抑制劑之單環嘧啶／吡啶化合物
AU2015206292B2 (en) 2014-01-20 2018-02-15 Cleave Biosciences, Inc. Fused pyrimidines as inhibitors of p97 complex
CN106458937A (zh) 2014-04-11 2017-02-22 巴斯夫欧洲公司 作为除草剂的二氨基三嗪衍生物
US10029992B2 (en) 2014-04-23 2018-07-24 Basf Se Diaminotriazine compounds and their use as herbicides
CR20160545A (es) 2014-04-23 2017-03-31 Basf Se Compuestos de diaminotriazina como herbicidas
AU2016249021A1 (en) 2015-04-17 2017-10-19 Assembly Biosciences, Inc. Hepatitis B viral assembly effectors
CN106518849B (zh) * 2016-10-27 2019-08-16 上海人类基因组研究中心 喹唑啉类化合物及其制备方法和用途
CN113727758A (zh) * 2019-03-01 2021-11-30 锐新医药公司 双环杂环基化合物及其用途
AU2023377192A1 (en) * 2022-11-07 2025-05-22 Kyoto University Nitrogen-containing heterocyclic compound

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ387292A3 (en) 1991-02-20 1994-04-13 Pfizer 2,4-diaminoquinazoline derivatives, process of their preparation and use as substances for increasing anti-tumorous activity
AU2002361846A1 (en) 2001-12-21 2003-07-15 Bayer Pharmaceuticals Corporation Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
AU2003255482A1 (en) 2002-10-02 2004-04-23 Merck Patent Gmbh Use of 4 amino-quinazolines as anti cancer agents
CN101031551A (zh) * 2004-07-06 2007-09-05 安吉永生物制药公司 针对癌症治疗的肝细胞生长因子/c－met活性的喹唑啉调节剂
WO2006105056A2 (en) * 2005-03-28 2006-10-05 Fmc Corporation Insecticidal 2,4-diaminoquinazolines and related derivatives
WO2007041282A2 (en) * 2005-09-29 2007-04-12 The Johns Hopkins University Methods and compositions for treatment of cystic fibrosis
US20090209536A1 (en) * 2007-06-17 2009-08-20 Kalypsys, Inc. Aminoquinazoline cannabinoid receptor modulators for treatment of disease
US20100317607A1 (en) * 2007-06-27 2010-12-16 Infectious Disease Research Institute Use of compounds for preparing anti-tuberculosis agents
US8637560B2 (en) 2007-07-18 2014-01-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Imidazolidinone compounds, methods to inhibit deubiquitination and methods of treatment
US9089572B2 (en) * 2008-01-17 2015-07-28 California Institute Of Technology Inhibitors of p97
WO2010003908A1 (en) 2008-07-08 2010-01-14 Jakobsson, Andreas Screening assay for compounds targeting the p97 aaa-atpase complex in the ubiquitin proteasome system.
US8865708B2 (en) 2010-05-07 2014-10-21 California Institute Of Technology Methods and compositions for inhibition of the transitional endoplasmic reticulum ATPase

Similar Documents

Publication Publication Date Title
JP2013530942A5 (https=)
CA2798698A1 (en) Methods and compositions for inhibition of the transitional endoplasmic reticulum atpase
AR083058A1 (es) Compuestos de estructura de imidazotriazinona
BR112012018865A2 (pt) naftiridinas substituídas e seu uso como inibidores de quinase syk
TW200833329A (en) 2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof
PE20091819A1 (es) DERIVADOS POLISUSTITUIDOS DE 2-HETEROARIL-6-FENIL-IMIDAZO[1,2-a] PIRIDINAS, SU PREPARACION Y SU APLIACION EN TERAPEUTICA
EP4245369A3 (en) Neuroactive steroids, compositions, and uses thereof
JP2013231086A (ja) 化学療法の強化方法
MY148636A (en) Benzimidazole derivatives
RU2013148922A (ru) Три- и тетрациклические пиразоло[3,4-в]пиридины в качестве антинеопластического средства
PE20091818A1 (es) DERIVADOS POLISUSTITUIDOS DE 2-ARIL-6-FENIL-IMIDAZO[1,2-a] PIRIDINAS, SU PREPARACION Y SU APLICACION EN TERAPEUTICA
JP2013513596A5 (https=)
RU2010117156A (ru) Гетероциклические соединения в качестве антагонистов crth2 рецептора
JP2013519653A5 (https=)
PE20130346A1 (es) Compuestos heterociclicos fusionados
JP2013525286A5 (https=)
MA32565B1 (fr) NOUVEAUX DERIVES IMIDAZO[1,2-a]PYRIDINE, LEUR PROCEDE DE PREPARATION, LEUR APPLICATION A TITRE DE MEDICAMENTS, COMPOSITIONS PHARMACEUTIQUES ET NOUVELLE UTILISATION NOTAMMENT COMME INHIBITEURS DE MET
DE602008001725D1 (de) 1-(1-benzylpiperidin-4-yl)benzimidazol-5-carbonsäurederivate zur behandlung von diabetes mellitus
BRPI0516453A (pt) derivados de benzoimidazol úteis como agentes antiproliferativos
JP2011517697A5 (https=)
US20110098291A1 (en) Antagonist of smoothened
NZ601077A (en) Use of an adrenal hormone-modifying agent
RU2011133128A (ru) Противоопухолевые соединения дигидропиран-2-она
JP2012502048A5 (https=)
JP2015500884A5 (https=)